Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 14, 2012

Primary Completion Date

June 22, 2013

Study Completion Date

June 22, 2013

Conditions
Orthostatic Hypotension
Interventions
DRUG

Midodrine HCl

dose at the subject's current dose level

DRUG

Placebo

single dose of matching placebo

Trial Locations (13)

10016

NYU Medical Centre, New York

10032

Columbia University, New York

14202

Buffalo Clinical Research Center (BCRC), Buffalo

33486

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

34653

Advance Research Institute Inc, New Port Richey

37920

New Orleans Center for Clinical Research - Knoxville, Knoxville

44195

Cleveland Clinic, Cleveland

53215

Aurora Cardiovascular Services, Milwaukee

55905

Mayo Clinic, Rochester

66219

Analab Clinical Research Inc, Lenexa

75069

The Heartbeat Clinic, PA, McKinney

84058

Aspen Clinical Research, Orem

97471

Kidney and Hypertension Center, Roseburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY

NCT01518946 - Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension | Biotech Hunter | Biotech Hunter